BACKGROUND/AIM: We examined the inhibitory effects of both glyoxalase 1 (GLO 1) and protein kinase C (PKC)λ in aldehyde dehydrogenase 1 (ALDH1)-positive breast cancer stem cells (CSCs). MATERIALS AND METHODS: Breast cancer genomics datasets (TCGA, n=593; METABRIC, n=1904) were downloaded and statistically analyzed. The effects of GLO 1 and PKCλ on trypan blue staining and tumor-sphere formation by ALDH1high cells derived from triple negative breast cancer (TNBC) and basal-like breast cancer were examined. RESULTS: GLO 1high, PKCλhigh, and ALDH1A3high tumors were enriched in stage I/II/III/IV samples, associated with the HER2 and TNBC subtypes according to receptor status, and associated with the HER2-enriched and basal-like subtypes according to PAM50. Inhibition of either GLO 1 (TLSC702) or PKCλ (ANF) suppressed tumor-sphere formation and enhanced death in ALDH1high cells. TLSC702 also effectively inhibited tumor-sphere formation and induced death in PKCλ knockout ALDH1high cells. CONCLUSION: GLO 1 and PKCλ are important for the survival of ALDH1-positive breast CSCs, and may represent potential therapeutic targets for the treatment of ALDH1-positive breast CSCs.
Aldehyde Dehydrogenase 1 Family/metabolism , Breast Neoplasms/metabolism , Isoenzymes/metabolism , Lactoylglutathione Lyase/metabolism , Neoplastic Stem Cells/metabolism , Protein Kinase C/metabolism , Aldehyde Dehydrogenase 1 Family/genetics , Biomarkers, Tumor , Breast Neoplasms/etiology , Breast Neoplasms/pathology , Cell Line, Tumor , Cell Survival , Female , Flow Cytometry , Gene Expression Profiling , Humans , Neoplasm Staging , Neoplastic Stem Cells/pathology , Transcriptome
